Immunai
New York, NY
Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.
immunai.comCompany Details
Founded
- 2018
Employees
- Between 100 - 200 employees
Raised
- $295,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Noam Solomon
Founders
- Ansuman SatpathyDan LittmanLuis VolochNoam SolomonDanny Wells
Company Collections
These are collections Immunai is a part of. Click on the collection name to view similar companies.